Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

YM155 treated KYSE410

ABSTRACT: We used microarrays to detail the gene expression profiles of KYSE410 cell line to identify distinct up and down-regulated genes during treatment with cisplatin.

ORGANISM(S): Homo sapiens

PROVIDER: GSE65009 | GEO | 2015/01/16

SECONDARY ACCESSION(S): PRJNA272710

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

YM155 treated KYSE410

Project description:We used microarrays to detail the gene expression profiles of KYSE410 cell line to identify distinct up and down-regulated genes during treatment with cisplatin. KYSE410 cell line were treated with 20 nM YM155 for 6 hrs and selected for RNA extraction and hybridization on Affymetrix microarrays. We sought to gene expression profiles of KYSE 410 cell line treated with cisplatin.

2015-01-16 | E-GEOD-65009 | biostudies-arrayexpress

CDDP treated KYSE140

Project description:We used microarrays to detail the gene expression profiles of KYSE140 cell line to identify distinct up and down-regulated genes during treatment with cisplatin.

2014-04-15 | GSE56769 | GEO

CDDP treated KYSE140

Project description:We used microarrays to detail the gene expression profiles of KYSE140 cell line to identify distinct up and down-regulated genes during treatment with cisplatin. KYSE140 cell line were treated with 10 mM cisplatin for 12 hrs and selected for RNA extraction and hybridization on Affymetrix microarrays. We sought to gene expression profiles of KYSE 140 cell line treated with cisplatin.

2014-04-15 | E-GEOD-56769 | biostudies-arrayexpress

mRNA expression of cytokine treated KYSE410 cells

Project description:KYSE410 cells were treated with PBS, TNFα, IL1β, and LPS respectively and mRNA expression profiles were assayed by Nimblegen gene expression microarray human HG18 (12x135K) Investigation of the critical gene participating various inflammatory stimuli in the process of ESCC progression.

2018-10-01 | GSE104768 | GEO

EDHB treated KYSE170

Project description:We used microarrays to detail the gene expression profiles of KYSE170 cell line to identify distinct up and down-regulated genes during treatment with ethyl-3,4-dihydroxybenzoate.

2014-05-29 | GSE58024 | GEO

mRNA expression of tumor-promoting molecules treated KYSE410 cells

Project description:KYSE410 cells were tranfected with NOX5 plasmid in the presence or absence of HIF-1α inhibitor-BAY87-2243 and mRNA expression of tumor-promoting molecules were assayed by RiboArray Human mRNA Array investigation of the critical gene participating in the process of NOX5/HIF-1α-mediated ESCC progression.

2019-12-31 | GSE112553 | GEO

mRNA expression of cytokine treated KYSE410 cells

Project description:mRNA expression of cytokine treated KYSE410 cells

| PRJNA413789 | ENA

Expression data from testicular germ cell tumor cells

Project description:To clarify the mechanism of cisplatin resistance in testicular germ cell tumor (TGCT), cisplatin-resistant TGCT cells (N8R and G9R) were generated from parental NEC8 cells (N8P) and TGCT patient-derived cells (TGCT-PDC)(G9P), respectively, by culture in medium containing cisplatin. We used microarrays to detail the global programme of gene expression underlying cisplatin resistance and identified up- and down-regulated genes during this process.

2022-10-17 | GSE197347 | GEO

Gene expression of KYSE410 cells with treatment of 10 uM FAK inhibitor (defactinib) for 4 hours and 24 hours

Project description:KYSE410 cells were treated with 10 uM defactinib for 4 hours and 24 hours,and KYSE410 cells were collected for gene expression analysis using Agilent SurePrint G3 Human Gene Expression v3 (8×60K) Microarray. Investigation of the critical gene of KYSE410 cells treated by defactinib.

2022-07-07 | GSE155591 | GEO

mRNA expression of tumor-promoting molecules treated KYSE410 cells

Project description:mRNA expression of tumor-promoting molecules treated KYSE410 cells

| PRJNA448172 | ENA